Monique C.J. Hanse

1.8k total citations
20 papers, 376 citations indexed

About

Monique C.J. Hanse is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Monique C.J. Hanse has authored 20 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Neurology. Recurrent topics in Monique C.J. Hanse's work include Glioma Diagnosis and Treatment (13 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Monique C.J. Hanse is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Monique C.J. Hanse collaborates with scholars based in Netherlands, Belgium and United States. Monique C.J. Hanse's co-authors include Martin J. van den Bent, Luc Crevits, Philippe Tummers, Georges Van Maele, Willem Jan van Rooij, M. Sluzewski, M.P.W.A. Houben, P. C. G. Nijssen, Walter Taal and Laurens V. Beerepoot and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Monique C.J. Hanse

20 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monique C.J. Hanse Netherlands 11 202 152 137 70 51 20 376
Vicent Quilis-Quesada Spain 9 135 0.7× 100 0.7× 51 0.4× 85 1.2× 62 1.2× 26 370
Esther Sánchez Aliaga Netherlands 12 148 0.7× 94 0.6× 44 0.3× 70 1.0× 24 0.5× 18 331
Jacques Grill France 8 323 1.6× 117 0.8× 164 1.2× 70 1.0× 19 0.4× 13 423
Barton S. Cooke United States 11 158 0.8× 157 1.0× 159 1.2× 203 2.9× 19 0.4× 23 398
John J. Demakas United States 13 168 0.8× 183 1.2× 164 1.2× 210 3.0× 18 0.4× 25 436
Massimo Napolitano Italy 9 164 0.8× 82 0.5× 149 1.1× 49 0.7× 21 0.4× 16 349
Mauro Palmieri Italy 10 111 0.5× 140 0.9× 52 0.4× 79 1.1× 41 0.8× 46 359
Wael Hassaneen United States 11 164 0.8× 89 0.6× 77 0.6× 107 1.5× 39 0.8× 29 386
Fabio Cofano Italy 10 175 0.9× 63 0.4× 66 0.5× 70 1.0× 31 0.6× 29 309
Alexis A. Morell United States 11 231 1.1× 102 0.7× 104 0.8× 91 1.3× 13 0.3× 47 370

Countries citing papers authored by Monique C.J. Hanse

Since Specialization
Citations

This map shows the geographic impact of Monique C.J. Hanse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monique C.J. Hanse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monique C.J. Hanse more than expected).

Fields of papers citing papers by Monique C.J. Hanse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monique C.J. Hanse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monique C.J. Hanse. The network helps show where Monique C.J. Hanse may publish in the future.

Co-authorship network of co-authors of Monique C.J. Hanse

This figure shows the co-authorship network connecting the top 25 collaborators of Monique C.J. Hanse. A scholar is included among the top collaborators of Monique C.J. Hanse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monique C.J. Hanse. Monique C.J. Hanse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gahrmann, Renske, Marion Smits, René M. Vernhout, et al.. (2022). The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab. Neuro-Oncology Advances. 4(1). vdac032–vdac032. 3 indexed citations
2.
Joode, Karlijn de, Walter Taal, Tom J. Snijders, et al.. (2021). Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium. Neuro-Oncology. 24(2). 326–328. 2 indexed citations
3.
Eekers, Daniëlle B. P., Anja Gijtenbeek, Monique C.J. Hanse, et al.. (2021). Glioma patient-reported outcomes: patients and clinicians. BMJ Supportive & Palliative Care. 13(e1). e205–e212. 4 indexed citations
4.
Rutten, Geert‐Jan, et al.. (2019). Predicting disease progression in high-grade glioma with neuropsychological parameters: the value of personalized longitudinal assessment. Journal of Neuro-Oncology. 144(3). 511–518. 15 indexed citations
5.
Gehring, Karin, Martijn M. Stuiver, Eva Visser, et al.. (2019). A pilot randomized controlled trial of exercise to improve cognitive performance in patients with stable glioma: a proof of concept. Neuro-Oncology. 22(1). 103–115. 43 indexed citations
6.
Bienfait, Henri P., Karl Dujardin, Monique C.J. Hanse, et al.. (2018). P01.037 Quality criteria for glioma care, use in clinical practice: results of a national survey. Neuro-Oncology. 20(suppl_3). iii236–iii237. 1 indexed citations
7.
Gahrmann, Renske, Martin J. van den Bent, Bronno van der Holt, et al.. (2017). Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial. Neuro-Oncology. 19(6). 853–861. 37 indexed citations
8.
Gahrmann, Renske, Martin J. van den Bent, Bronno van der Holt, et al.. (2016). NIMG-13. RADIOLOGICAL RESPONSE ASSESSMENT IN THE ERA OF BEVACIZUMAB: RANO OR VOLUMETRY? A REPORT FROM THE BELOB TRIAL. Neuro-Oncology. 18(suppl_6). vi126–vi126. 1 indexed citations
9.
10.
Dirven, Linda, Martin J. van den Bent, Andrew Bottomley, et al.. (2015). The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trial. European Journal of Cancer. 51(10). 1321–1330. 37 indexed citations
11.
12.
French, Pim J., Lale Erdem‐Eraslan, Johan M. Kros, et al.. (2014). IDENTIFICATION OF PATIENTS WITH RECURRENT GBM THAT BENEFIT FROM BEVACIZUMAB. Neuro-Oncology. 16(suppl 3). iii8–iii9. 1 indexed citations
13.
Taal, Walter, Hendrika M. Oosterkamp, Annemiek Walenkamp, et al.. (2013). A randomized phase II study of bevacizumab versus bevacizumab plus lomustine versus lomustine single agent in recurrent glioblastoma: The Dutch BELOB study.. Journal of Clinical Oncology. 31(15_suppl). 2001–2001. 44 indexed citations
14.
Simkens, Geert A., Monique C.J. Hanse, & Ignace H. J. T. de Hingh. (2012). Acute neurological disorders following intraperitoneal administration of cisplatin. International Journal of Gynecology & Obstetrics. 120(3). 291–291. 1 indexed citations
15.
Hanse, Monique C.J., et al.. (2008). Recovery of Posterior Communicating Artery Aneurysm-Induced Oculomotor Palsy after Coiling. American Journal of Neuroradiology. 29(5). 988–990. 58 indexed citations
16.
Hanse, Monique C.J., et al.. (2008). Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment. Journal of Neurology. 255(6). 828–830. 33 indexed citations
17.
Hanse, Monique C.J., et al.. (2007). Hemangioblastomatosis in a patient with von Hippel-Lindau disease. Journal of Neuro-Oncology. 82(2). 163–164. 15 indexed citations
18.
Hanse, Monique C.J., et al.. (2006). Two exceptional phenomena in an anaplastic oligo-astrocytoma. Journal of Neuro-Oncology. 78(2). 197–197. 1 indexed citations
19.
Crevits, Luc, Monique C.J. Hanse, Philippe Tummers, & Georges Van Maele. (2000). Antisaccades and remembered saccades in mild traumatic brain injury. Journal of Neurology. 247(3). 179–182. 42 indexed citations
20.
Crevits, Luc, et al.. (2000). Antisaccadic Effects of a Dopamine Agonist as Add-On Therapy in Advanced Parkinson’s Patients. Neuropsychobiology. 42(4). 202–206. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vicent Quilis-Quesada Breakdown of academic impact, for papers by Esther Sánchez Aliaga Breakdown of academic impact, for papers by Jacques Grill Breakdown of academic impact, for papers by Barton S. Cooke Breakdown of academic impact, for papers by John J. Demakas Breakdown of academic impact, for papers by Massimo Napolitano Breakdown of academic impact, for papers by Mauro Palmieri Breakdown of academic impact, for papers by Wael Hassaneen Breakdown of academic impact, for papers by Fabio Cofano Breakdown of academic impact, for papers by Alexis A. Morell
Rankless by CCL
2026